gemcitabine has been researched along with calcitriol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adorini, L; Daniel, KC; Penna, G | 1 |
| Johnson, CS; Ma, Y; Trump, DL; Yu, WD | 1 |
| Flynn, G; Johnson, CS; Kong, RX; Ma, Y; Muindi, JR; Trump, DL; Yu, WD | 1 |
| Boroujerdi, M; Gilzad-Kohan, H; Sani, S | 1 |
1 review(s) available for gemcitabine and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for gemcitabine and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Vitamin D receptor agonists, cancer and the immune system: an intricate relationship.
Topics: Calcitriol; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Doxorubicin; Drug Synergism; Epirubicin; Gemcitabine; Humans; Molecular Structure; Receptors, Calcitriol; Structure-Activity Relationship; Urinary Bladder Neoplasms | 2006 |
1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcitriol; Cell Line, Tumor; Cell Proliferation; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Humans; Mice; Mice, Nude; Nuclear Proteins; Receptors, Calcitriol; Tumor Protein p73; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Vitamin D; Xenograft Model Antitumor Assays | 2010 |
Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Calcitriol; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Disease Models, Animal; Drug Synergism; Enzyme Activation; Gemcitabine; Humans; Liver; Mice; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Xenograft Model Antitumor Assays | 2010 |
Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells.
Topics: Adenosine Triphosphatases; Antimetabolites, Antineoplastic; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Calcitriol; Calcium Channel Agonists; Carrier Proteins; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Silybin; Silymarin | 2017 |